Genmab reported DKK416M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agios Pharmaceuticals AGIO:US $ 0.53M 0.08M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 36854M 3545M
Artemis Alpha ATS:LN 0 0
AstraZeneca AZN:LN 31099M 318M
Bayer BAYN:GR € 42547M 1675M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Exelixis EXEL:US $ 0M 0M
Fresenius Medical Care FME:GR € 13343.37M 23.22M
Galapagos GLPG:NA € 25.35M 1.5M
Genmab GEN:DC DK 416M 9M
GlaxoSmithKline GSK:LN 33328M 9155M
GN Store Nord GN:DC DK 15186M 3620M
GRIFOLS GRF:SM € 7933.89M 565.82M
H. Lundbeck A/S LUN:DC 6.47B 1.15B
Hikma Pharmaceutical HIK:LN 846M 86M
Immunogen IMGN:US $ 0M 0M
Insmed INSM:US $ 806.79M 225.49M
Lonza Group LONN:SW 2.4B 1.24B
Merck MRK:GR € 10631M 170M
Novartis NOVN:VX SF 31275M 250M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 0.7M
Seattle Genetics SGEN:US $ 0M 0M
William Demant Holding WDH:DC 11.34B 601M